Dioxolane and dioxolanone fused indolobenzadiazepine HCV NS5B inhibitors

Details for Australian Patent Application No. 2009228214 (hide)

Owner BRISTOL-MYERS SQUIBB COMPANY

Inventors Yang, Zhong; Bender, John A.; Kadow, John F.

Agent A J Park

Pub. Number AU-A-2009228214

PCT Pub. Number WO2009/120890

Priority 61/039,967 27.03.08 US

Filing date 26 March 2009

Wipo publication date 1 October 2009

International Classifications

C07D 491/056 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

23 September 2010 PCT application entered the National Phase

  PCT publication WO2009/120890 Priority application(s): WO2009/120890

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009228215-Differentiation of primate pluripotent stem cells to hematopoietic lineage cells

2009228205-Methods for improving lid margin and tear film function and treatment of lid margin disease using tetracycline family antibiotics